- Home
- CLDX vs EVT Comparison
CLDX vs EVT Comparison
Compare CLDX & EVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDX
- EVT
- Stock Information
- Founded
- CLDX N/A
- EVT 2003
- Country
- CLDX United States
- EVT United States
- Employees
- CLDX N/A
- EVT N/A
- Industry
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- EVT Finance Companies
- Sector
- CLDX Health Care
- EVT Finance
- Exchange
- CLDX Nasdaq
- EVT Nasdaq
- Market Cap
- CLDX 1.6B
- EVT 1.9B
- IPO Year
- CLDX 2008
- EVT N/A
- Fundamental
- Price
- CLDX $26.77
- EVT $24.26
- Analyst Decision
- CLDX Buy
- EVT
- Analyst Count
- CLDX 9
- EVT 0
- Target Price
- CLDX $43.78
- EVT N/A
- AVG Volume (30 Days)
- CLDX 958.4K
- EVT 115.5K
- Earning Date
- CLDX 11-05-2025
- EVT 01-01-0001
- Dividend Yield
- CLDX N/A
- EVT 8.32%
- EPS Growth
- CLDX N/A
- EVT N/A
- EPS
- CLDX N/A
- EVT 6.63
- Revenue
- CLDX $5,790,000.00
- EVT $69,404,302.00
- Revenue This Year
- CLDX N/A
- EVT N/A
- Revenue Next Year
- CLDX N/A
- EVT N/A
- P/E Ratio
- CLDX N/A
- EVT $3.55
- Revenue Growth
- CLDX N/A
- EVT N/A
- 52 Week Low
- CLDX $14.40
- EVT $19.20
- 52 Week High
- CLDX $29.93
- EVT $25.83
- Technical
- Relative Strength Index (RSI)
- CLDX 56.87
- EVT 47.00
- Support Level
- CLDX $26.10
- EVT $24.15
- Resistance Level
- CLDX $27.87
- EVT $24.61
- Average True Range (ATR)
- CLDX 1.18
- EVT 0.33
- MACD
- CLDX -0.07
- EVT -0.03
- Stochastic Oscillator
- CLDX 67.91
- EVT 30.45
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
About EVT Eaton Vance Tax Advantaged Dividend Income Fund of Beneficial Interest
EATON VANCE TAX ADVANTAGED DIVIDEND INCOME FUND is a diversified, closed-end management investment company. Its objective is to provide a high level of after-tax total return consisting mainly of tax-advantaged dividend income and capital appreciation. The fund pursues its objective by investing in dividend-paying common and preferred stocks. Its portfolio of investments consists of electric utilities, energy equipment and services, food products, health care providers and services, internet software and services, and other areas.